MEDICAMEQ MTF Data: Margin Funding in Medicamen Biotech Limited
Medicamen Biotech Limited has no margin-funded position on the latest exchange disclosure.
MEDICAMEQ MTF book and price
Daily for the last two years, weekly before that. The book is the exchange-reported amount financed.
Holders' cost vs the market
Amount financed ÷ shares financed approximates the average price margin holders paid. When the close is below that line, margin holders are, on average, sitting on a loss.
Shares financed
Share counts move only when margin holders buy or sell (and on splits and bonuses), not with the price.
Net new margin buying, by month
Each day's change in shares financed valued at that day's close, summed by month: buying and selling on margin without the effect of price. Split and bonus credits are removed.
Leverage and days to cover
Share of the company's shares on margin (month end) and how many days of average NSE volume they equal.
Records & stats
| Latest book | ₹0 |
| Flow: 1 / 5 / 20 sessions | +₹0 · +₹0 · −₹4.8 L |
| Change: 1 week / 1 month / 3 months / 1 year | — · -100.0% · -100.0% · -100.0% |
| All-time high | ₹5.06 Cr 28 Jul 2022 |
| Low since first funded | ₹0 15 Oct 2026 |
| Biggest one-day build | +₹1.55 Cr 1 Feb 2022 |
| Biggest one-day unwind | −₹1.37 Cr 20 Jan 2022 |
| Below its peak | 100.0% |
| Average book while funded | ₹1.80 Cr |
| Most shares financed | 96,436 18 Feb 2022 |
| Funded since | 6 Dec 2021 (1,168 sessions with a book) |
Month by month
| Month | Book | Net buying | % of shares | Days to cover |
|---|---|---|---|---|
| 2026-10 | ₹0 | −₹2.7 L | 0.00% | 0.0 |
| 2026-09 | ₹4.3 L | −₹41.3 L | 0.01% | 0.0 |
| 2026-08 | ₹59.3 L | +₹4.7 L | 0.10% | 0.5 |
| 2026-07 | ₹54.8 L | −₹1.4 L | 0.08% | 0.5 |
| 2026-06 | ₹56.5 L | −₹80,000 | 0.09% | 0.3 |
| 2026-05 | ₹57.5 L | −₹20,000 | 0.09% | 0.5 |
| 2026-04 | ₹57.8 L | −₹70.1 L | 0.09% | 0.3 |
| 2026-03 | ₹1.37 Cr | +₹67.9 L | 0.32% | 1.0 |
| 2026-02 | ₹72.4 L | −₹4.1 L | 0.12% | 0.7 |
| 2026-01 | ₹77.6 L | +₹1.8 L | 0.12% | 0.6 |
| 2025-12 | ₹75.8 L | −₹40,000 | 0.12% | 0.6 |
| 2025-11 | ₹76.4 L | +₹9.5 L | 0.12% | 0.2 |
Other Pharmaceuticals & Biotechnology stocks on margin
Questions
How much margin trading funding does MEDICAMEQ have?
On 23 Oct 2026, ₹0 of Medicamen Biotech Limited shares were held under the margin trading facility.
What share of MEDICAMEQ is bought on margin?
Not available for this security.
Are margin holders of MEDICAMEQ in profit?
Not available for this security.
Where does this data come from?
Exchange data: the daily margin trading disclosures, with prices and share counts from the exchange. See the methodology.
Figures for the 23 Oct 2026 session · last updated 2026-10-26 22:47 IST · Source: Exchange data · 10/10 data checks passed.
How to read this page. Everything here describes what the exchanges have already disclosed about margin-funded (MTF) positions. It is not a forecast, a recommendation, or a signal to buy or sell. Words such as "crowded", "fragile" or "underwater" name a pattern in the numbers, nothing more. Margin funding carries the risk of losses larger than the money you put in.
Flash Finance is not a SEBI-registered investment adviser and is not affiliated with NSE, BSE or SEBI. Exchange data may be revised by the exchange. Verify anything you intend to act on against the exchange's own records.
